Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis

Cell Transplantation

Volumn 22, Issue 5, 2013, Pages 779-795

  Scuderi, Nicolò ^a   Ceccarelli, Simona ^b   Onesti, Maria Giuseppina ^a   Fioramonti, Paolo ^a   Guidi, Chiara ^c   Romano, Ferdinando ^d   Frati, Luigi ^d   Angeloni, Antonio ^b   Marchese, Cinzia ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Bioscience Institute   (San Marino)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adipose tissue engineering; Hyaluronic acid (HA); Mesenchymal stromal cell (MSC); Transplantation

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BETA1 INTEGRIN; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; HYALURONIC ACID; THY 1 ANTIGEN;

ADIPOGENESIS; ADIPOSE DERIVED STROMAL CELL; ADULT; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CELL VIABILITY; CHONDROGENESIS; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; LIPOSUCTION; MALE; PRIORITY JOURNAL; SCLERODERMA; SKIN; STROMA CELL; SUBCUTANEOUS FAT; SYSTEMIC SCLEROSIS;

ADIPOSE TISSUE; ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; FEMALE; HUMANS; HYALURONIC ACID; MALE; PHENOTYPE; SCLERODERMA, SYSTEMIC; SKIN; STROMAL CELLS; TISSUE ENGINEERING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876353108     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X639017     Document Type: Article

References (63)

1. Altman, A. M.; Abdul Khalek, F. J.; Seidensticker, M.; Pinilla, S.; Yan, Y.; Coleman, M.; Song, Y. H.; Butler, C. E.; Alt, E. U. Human tissue-resident stem cells combined with hyaluronic acid gel provide fibrovascular-integrated softtissue augmentation in a murine photoaged skin model. Plast. Reconstr. Surg. 125(1):63-73; 2010.
2. Arkachaisri, T.; Vilaiyuk, S.; Li, S.; O'Neil, K. M.; Pope, E.; Higgins, G. C.; Punaro, M.; Rabinovich, E. C.; Rosenkranz, M.; Kietz, D. A.; Rosen, P.; Spalding, S. J.; Hennon, T. R.; Torok, K. S.; Cassidy, E.; Medsger, T. A., Jr. Localized Scleroderma Clinical and Ultrasound Study Group. The localized scleroderma skin severity index and physician global assessment of disease activity: A work in progress toward development of localized scleroderma outcome measures. J. Rheumatol. 36(12):2819-2829; 2009.
3. Bernardo, M. E.; Pagliara, D.; Locatelli, F. Mesenchymal stromal cell therapy: A revolution in regenerative medicine? Bone Marrow Transplant. 47(2):164-171; 2012.
4. Carruthers, A.; Carruthers, J. Non-animal-based hyaluronic acid fillers: Scientific and technical considerations. Plast. Reconstr. Surg. 120:33S-40S; 2007.
5. Coleman, S. R. Structural fat grafts: The ideal filler? Clin. Plast. Surg. 28:111-119; 2001.
6. Cooperman, L. S.; Mackinnon, V.; Bechler, G.; Pharriss, B. B. Injectable collagen: A six-year clinical investigation. Aesthetic Plast. Surg. 9(2):145-151; 1985.
7. Ding, D. C.; Shyu, W. C.; Lin, S. Z. Mesenchymal stem cells. Cell Transplant. 20(1):5-14; 2011.
8. R. Transplantation of purified autologous fat: A 3-year follow-up is disappointing. Plast. Reconstr. Surg. 87:219-227; 1991.
9. Fagien, S.; Klein, A. W. A brief overview and history of temporary fillers: Evolution, advantages, and limitations. Plast. Reconstr. Surg. 120:8S-16S; 2007.
10. Fett, N.; Werth, V. P. Update on morphea: Part I. Epidemiology, clinical presentation, and pathogenesis. J. Am. Acad. Dermatol. 64(2):217-228; 2011.
11. Fiorina, P.; Jurewicz, M.; Augello, A.; Vergani, A.; Dada, S.; La Rosa, S.; Selig, M.; Godwin, J.; Law, K.; Placidi, C.; Smith, R. N.; Capella, C.; Rodig, S.; Adra, C. N.; Atkinson, M.; Sayegh, M. H.; Abdi, R. Immunomodulatory function of bone marrow derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J. Immunol. 183:993-1004; 2009.
12. Fischer, L. J.; McIlhenny, S.; Tulenko, T.; Golesorkhi, N.; Zhang, P.; Larson, R.; Lombardi, J.; Shapiro, I.; DiMuzio, P. J. Endothelial differentiation of adipose-derived stem cells: Effects of endothelial cell growth supplement and shear force. J. Surg. Res. 152(1):157-166; 2009.
13. Frisbie, D. D.; Kisiday, J. D.; Kawcak, C. E.; Werpy, N. M.; McIlwraith, C. W. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. J. Orthop. Res. 27(12):1675-1680; 2009.
14. Gimble, J. M.; Katz, A. J.; Bunnel, B. A. Adipose-derived stem cells for regenerative medicine. Circ. Res. 100:1249-1260; 2007.
15. González, M. A.; Gonzalez-Rey, E.; Rico, L.; Büscher, D.; Delgado, M. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136:978-989; 2009.
16. Gronthos, S.; Franklin, D. M.; Leddy, H. A.; Robey, P. G.; Storms, R. W.; Gimble, J. M. Surface protein characterization of human adipose tissue-derived stromal cells. J. Cell. Physiol. 189(1):54-63; 2001.
17. Haustein, U. F. Systemic sclerosis-scleroderma. Dermatol. Online J. 8(1):3; 2002.
18. Hayashi, Y.; Tsuji, S.; Tsujii, M.; Nishida, T.; Ishii, S.; Iijima, H.; Nakamura, T.; Eguchi, H.; Miyoshi, E.; Hayashi, N.; Kawano, S. Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats. J. Pharmacol. Exp. Ther. 326:523-531; 2008.
19. Homicz, M. R.; Watson, D. Review of injectable materials for soft tissue augmentation. Facial Plast. Surg. 20(1):21-29; 2004.
20. Itoi, Y.; Takatori, M.; Hyakusoku, H.; Mizuno, H. Comparison of readily available scaffolds for adipose tissue engineering using adipose-derived stem cells. J. Plast. Reconstr. Aesthet. Surg. 63(5):858-864; 2010.
21. Izadpanah, R.; Trygg, C.; Patel, B.; Kriedt, C.; Dufour, J.; Gimble, J. M.; Bunnell, B. A. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J. Cell. Biochem. 99(5):1285-1297; 2006.
22. Jiang, D.; Liang, J.; Noble, P. W. Hyaluronan as an immune regulator in human diseases. Physiol. Rev. 91(1):221-264; 2011.
23. M. Mechanisms of skin fibrosis in systemic sclerosis. J. Dermatol. 37(1):11-25; 2010.
24. Johnson, R. W.; Tew, M. B.; Arnett, F. C. The genetics of systemic sclerosis. Curr. Rheumatol. Rep. 4(2):99-107; 2002.
25. Jurewicz, M.; Yang, S.; Augello, A.; Godwin, J. G.; Moore, R. F.; Azzi, J.; Fiorina, P.; Atkinson, M.; Sayegh, M. H.; Abdi, R. Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type I diabetes. Diabetes 59:3139-3147; 2010.
26. Jurgens, W. J.; Oedayrajsingh-Varma, M. J.; Helder, M. N.; Zandiehdoulabi, B.; Schouten, T. E.; Kuik, D. J.; Ritt, M. J.; van Milligen, F. J. Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: Implications for cell-based therapies. Cell Tissue Res. 332(3):415-426; 2008.
27. Khanna, D.; Denton, C. P. Evidence-based management of rapidly progressing systemic sclerosis. Best Pract. Res. Clin. Rheumatol. 24(3):387-400; 2010.
28. Kijima, Y.; Yoshinaka, H.; Funasako, Y.; Kaneko, K.; Hirata, M.; Mizoguchi, T.; Ishigami, S.; Arima, H.; Nakajo, A.; Ueno, S.; Natsugoe, S. Immediate breast reconstruction using autologous free dermal fat grafts provides better cosmetic results for patients with upper inner cancerous lesions. Surg, Today 41(4):477-489; 2011.
29. Krieg, T.; Takehara, K. Skin disease: A cardinal feature of systemic sclerosis. Rheumatology 48(Suppl. 3):iii, 14-18; 2009.
30. Kunter, U.; Rong, S.; Djuric, Z.; Boor, P.; Müller-Newen, G.; Yu, D.; Floege, J. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J. Am. Soc. Nephrol. 17:2202-2212; 2006.
31. Larghero, J.; Farge, D.; Braccini, A.; Lecourt, S.; Scherberich, A.; Foïs, E.; Verrecchia, F.; Daikeler, T.; Gluckman, E.; Tyndall, A.; Bocelli-Tyndall, C. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis. Ann. Rheum. Dis. 67(4):443-449; 2008.
32. LeRoy, E. C.; Black, C.; Fleischmajer, R.; Jablonska, S.; Krieg, T.; Medsger, T. A., Jr; Rowell, N.; Wollheim, F. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J. Rheumatol. 15:202-205; 1988.
33. Liang, J.; Zhang, H.; Hua, B.; Wang, H.; Lu, L.; Shi, S.; Hou, Y.; Zeng, X.; Gilkeson, G. S.; Sun, L. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: A pilot clinical study. Ann. Rheum. Dis. 69(8):1423-1429; 2010.
34. Locke, M.; Windsor, J.; Dunbar, P. R. Human adiposederived stem cells: Isolation, characterization and applications in surgery. ANZ J. Surg. 79(4):235-244; 2009.
35. Matucci-Cerinic, M.; Steen, V.; Nash, P.; Hachulla, E. The complexity of managing systemic sclerosis: Screening and diagnosis. Rheumatology (Oxford) 48 (Suppl. 3):iii, 8-13; 2009.
36. Merceron, C.; Portron, S.; Masson, M.; Lesoeur, J.; Fellah, B. H.; Gauthier, O.; Geffroy, O.; Weiss, P.; Guicheux, J.; Vinatier, C. The effect of two and three dimensional cell culture on the chondrogenic potential of human adiposederived mesenchymal stem cells after subcutaneous transplantation with an injectable hydrogel. Cell Transplant. 20(10):1575-1588; 2011.
37. Milano, A.; Pendergrass, S. A.; Sargent, J. L.; George, L. K., McCalmont, T. H.; Connolly, M. K.; Whitfield, M. L. Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One 3(7):e2696; 2008.
38. Moseley, T. A.; Zhu, M.; Hedrick, M. H. Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast. Reconstr. Surg. 118(Suppl. 3):121S-128S; 2006.
39. Nash, R. A.; McSweeney, P. A.; Crofford, L. J.; Abidi, M.; Chen, C. S.; Godwin, J. D.; Gooley, T. A.; Holmberg, L.; Henstorf, G.; LeMaistre, C. F.; Mayes, M. D.; McDonagh, K. T.; McLaughlin, B.; Molitor, J. A.; Nelson, J. L.; Shulman, H.; Storb, R.; Viganego, F.; Wener, M. H.; Seibold, J. R.; Sullivan, K. M.; Furst, D. E. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: Long-term follow-up of the US multicenter pilot study. Blood 110(4):1388-1396; 2007.
40. Ning, H.; Liu, G.; Lin, G.; Yang, R.; Lue, T. F.; Lin, C. S. Fibroblast growth factor 2 promotes endothelial differentiation of adipose tissue-derived stem cells. J. Sex. Med. 6(4):967-979; 2009.
41. Perricone, R.; Galante, V.; Bernardini, S.; Guarino, M.; Cervelli, V. Fillers and biocompatibility: Lack of human complement activating capacity. Plast. Reconstr. Surg. 121(3):154e-155e; 2008.
42. Peterson, L. S.; Nelson, A. M.; Su, W. P. Classification of morphea, localized scleroderma. Mayo Clin. Proc. 70:1068-1076; 1995.
43. Planat-Benard, V.; Silvestre, J. S.; Cousin, B.; André, M.; Nibbelink, M.; Tamarat, R.; Clergue, M.; Manneville, C.; Saillan-Barreau, C.; Duriez, M.; Tedgui, A.; Levy, B.; Pénicaud, L.; Casteilla, L. Plasticity of human adipose lineage cells toward endothelial cells: Physiological and therapeutic perspectives. Circulation 109(5):656-663; 2004.
44. Puissant, B.; Barreau, C.; Bourin, P.; Clavel, C.; Corre, J.; Bousquet, C.; Taureau, C.; Cousin, B.; Abbal, M.; Laharrague, P.; Penicaud, L.; Casteilla, L.; Blancher, A. Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br. J. Haematol. 129:118-129; 2005.
45. Qi, Q.; Guo, Q.; Tan, G.; Mao, Y.; Tang, H.; Zhou, C.; Zeng, F. Predictors of the scleroderma phenotype in fibroblasts from systemic sclerosis patients. J. Eur. Acad. Dermatol. Venereol. 23(2):160-168; 2009.
46. Rehman, J.; Traktuev, D.; Li, J.; Merfeld-Clauss, S.; Temm-Grove, C. J.; Bovenkerk, J. E.; Pell, C. L.; Johnstone, B. H.; Considine, R. V.; March, K. L. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109(10):1292-1298; 2004.
47. Riordan, N. H.; Ichim, T. E.; Min, W. P.; Wang, H.; Solano, F.; Lara, F.; Alfaro, M.; Rodriguez, J. P.; Harman, R. J.; Patel, A. N.; Murphy, M. P.; Lee, R. R.; Minev, B. Nonexpanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J. Transl. Med. 7:29; 2009.
48. Sterodimas, A.; de Faria, J.; Nicaretta, B.; Pitanguy, I. Tissue engineering with adipose-derived stem cells (ADSCs): Current and future applications. J. Plast. Reconstr. Aesthet. Surg. 63(11):1886-1892; 2010.
49. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic, and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 23:581-590; 1980.
50. Summers, B. K.; Siegle, R. J. Facial cutaneous reconstructive surgery: Facial flaps. J. Am. Acad. Dermatol. 29(6):917-941; 1993.
51. Szöke, K.; Beckstrøm, K. J.; Brinchmann, J. E. Human adipose tissue as a source of cells with angiogenic potential. Cell Transplant. 21(1):235-250; 2012.
52. Tan, F. K.; Arnett, F. C. Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon. Curr. Opin. Rheumatol. 12(6):511-519; 2000.
53. Tan, H.; Ramirez, C. M.; Miljkovic, N.; Li, H.; Rubin, J. P.; Marra, K. G. Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineering. Biomaterials 30(36):6844-6853; 2009.
54. van Paassen, P.; Duijvestijn, A.; Debrus-Palmans, L.; Damoiseaux, J.; Vroomen, M.; Tervaert, J. W. Induction of endothelial cell apoptosis by IgG antibodies from SLE patients with nephropathy: A potential role for anti-endothelial cell antibodies. Ann. N. Y. Acad. Sci. 1108:147-156; 2007.
55. van Poll, D.; Parekkadan, B.; Cho, C. H.; Berthiaume, F.; Nahmias, Y.; Tilles, A. W.; Yarmush, M. L. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 47:1634-1643; 2008.
56. Wang, F.; Garza, L. A.; Kang, S.; Varani, J.; Orringer, J. S.; Fisher, G. J.; Voorhees, J. J. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch. Dermatol. 143:155-163; 2007.
57. Yoshimura, K.; Sato, K.; Aoi, N.; Kurita, M.; Hirohi, T.; Harii, K. Cell-assisted lipotransfer for cosmetic breast augmentation: Supportive use of adipose-derived stem/stromal cells. Aesthetic Plast. Surg. 32(1):48-55; 2008.
58. Yoshimura, K.; Sato, K.; Aoi, N.; Kurita, M.; Inoue, K.; Suga, H.; Eto, H.; Kato, H.; Hirohi, T.; Harii, K. Cellassisted lipotransfer for facial lipoatrophy: Efficacy of clinical use of adipose-derived stem cells. Dermatol. Surg. 34(9):1178-1185; 2008.
59. Yu, J.; Zheng, C.; Ren, X.; Li, J.; Liu, M.; Zhang, L.; Liang, L.; Du, W.; Han, Z. C. Intravenous administration of bone marrow mesenchymal stem cells benefits experimental autoimmune myasthenia gravis mice through an immunomodulatory action. Scand. J. Immunol. 72(3):242-249; 2010.
60. Zhu, Y.; Liu, T.; Song, K.; Fan, X.; Ma, X.; Cui, Z. Adiposederived stem cell: A better stem cell than BMSC. Cell Biochem. Funct. 26(6):664-675; 2008.
61. Zuber, J. P.; Spertini, F. Immunological basis of systemic sclerosis. Rheumatology (Oxford). 45(Suppl. 3):iii, 23-25; 2006.
62. Zuk, P. A.; Zhu, M.; Ashjian, P.; De Ugarte, D. A.; Huang, J. I.; Mizuno, H.; Alfonso, Z. C.; Fraser, J. K.; Benhaim, P.; Hedrick, M. H. Human adipose tissue is a source of multipotent stem cells. Mol. Cell. Biol. 13:4279-4295; 2002.
63. Zuk, P. A.; Zhu, M.; Mizuno, H.; Huang, J.; Futrell, J. W.; Katz, A. J.; Benhaim, P.; Lorenz, H. P.; Hedrick, M. H. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 7:221-228; 2001.